Mirtazapina Psidep 15 Mg Comprimidos Revestidos (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonizes postsynaptic 5‑HT2 and 5‑HT3 receptors while sparing 5‑HT1A, resulting in enhanced noradrenergic and serotonergic neurotransmission that contributes to its antidepressant effect.

The appropriate dose is determined by the prescribing clinician based on the individual’s clinical condition. In practice, clinicians often start with a 15 mg oral tablet taken once daily and may adjust the dose upward or downward according to therapeutic response and tolerability.

Safety data for mirtazapine during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, whereas many other antidepressants are selective serotonin reuptake inhibitors (SSRIs). Compared with SSRIs, mirtazapine often causes more sedation and weight gain but may be preferred when patients experience insomnia or poor appetite. Both classes are effective for depression, and the choice depends on individual symptom profile and tolerability.

Mirtazapina Psidep 15 Mg Comprimidos Revestidos should be stored at ambient temperature, below 25 °C, in the original blister pack. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

The tablets are taken orally, usually once daily in the evening or as directed by a healthcare professional. They should be swallowed whole with water and not crushed or chewed unless otherwise advised by a prescriber.

Serious risks include the emergence of suicidal thoughts, especially during the initial treatment period, severe neutropenia or agranulocytosis, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of infection, unexplained fever, severe rash, or worsening mood.

Mirtazapine is contraindicated in individuals who have taken a monoamine oxidase inhibitor within the past 14 days, as well as those with known hypersensitivity to the drug. Caution is also advised for patients with severe hepatic impairment, uncontrolled epilepsy, or a history of bipolar disorder with manic episodes.